ghk-cu copper peptide uses GHK-CU - Research Peptide -
Description
Approximately 50-98% of the injected cyanocobalamin is in the urine, mostly excreted within the first eight hours

View GHK-Cu (Copper Peptide)
Although not the focus of this study, an obvious question relates to the identity of the molecular target responsible for the procognitive and synaptogenic activity of dihexa and other AngIV-related compounds

[DOI] [PubMed] [Google Scholar] 51.Bhathena S.J., Recant L., Voyles N.R., Timmers K.I., Reiser S., Smith J.C.J., Powell A.S

The following are suggested dosages, depending on the condition of the animal and the desired response

Its reported effects on modulating inflammatory pathways make it a candidate for managing arthritis, joint pain, and other inflammatory disorders
